Cleared Traditional

K822536 - MARK V

K822536 is an FDA 510(k) clearance for MARK V, manufactured by Medrad, Inc.. The device is a Class 2 Cardiovascular device with product code DXT cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K822536 · Medrad, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1982
Decision
35d
Days
Class 2
Risk

K822536 is an FDA 510(k) clearance for the MARK V. Classified as Injector And Syringe, Angiographic (product code DXT), Class II - Special Controls.

Submitted by Medrad, Inc. (Walker, US). The FDA issued a Cleared decision on September 28, 1982 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1650 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medrad, Inc. devices

FDA 510(k) Submission Details - K822536

510(k) Number K822536 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 1982
Decision Date September 28, 1982
Days to Decision 35 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
90d faster than avg
Panel avg: 125d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXT Device Classification - Class 2, Special Controls

Product Code DXT Injector And Syringe, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXT Injector And Syringe, Angiographic

All 168
Devices cleared under the same product code (DXT) and FDA review panel - the closest regulatory comparables to K822536.
REUSABLE METAL STOPCOCK
K823254 · Vertex Medical Corp. · Dec 1982
ULTRA-ASEPT ANGIOGRAPHIC SYRINGE/SPARE
K823256 · Vertex Medical Corp. · Dec 1982
CLEAR VINYL MONITORING CONNECTOR
K823340 · Vertex Medical Corp. · Dec 1982
QUICK FILL
K800823 · Medrad, Inc. · Apr 1980
ANGIOPLASTY INJECTOR
K800613 · Medrad, Inc. · Apr 1980
USCI BALLOON DILATATION INFLATION DEV.
K791782 · C.R. Bard, Inc. · Dec 1979